Argenx
argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer.
View Top Employees for argenx
Website | argen-x.com | |
Industry | Biotechnology | |
Location | Zwijnaarde, East Flanders Province, Belgium | |
Founded | 2008 |
HQ | 33 Arch Street, 32nd Floor | |
Funding | 700,000,000 USD |
Website | ||
Industry | Biotechnology | |
Employees | 57 | |
Founded | 2008 | |
HQ | 33 Arch Street, 32nd Floor | |
Funding | 700000000 |
Top Competitor for Argenx
Argenx Questions
Where are argenx's headquarters?
argenx's headquarters are in 33 Arch Street, 32nd Floor
What is argenx's official website?
argenx's website is argen-x.com
How many employees are working in argenx right now?
argenx has
57 employees.
View the Email and Phone Numbers for all 57 working at argenx.
What is argenx's industry?
argenx's industry is
Biotechnology
Who are argenx's top competitors?
argenx's top competitors are
Roche
,
Agilent Technologies
,
Amgen
,
Genentech
,
Eurofins
,
Gilead Sciences
,
Lonza
,
Charles River Laboratories
,
Sanofi Genzyme
,
Biogen
What are argenx's categories?
argenx's categories are -
What is argenx's location?
argenx's location is
Zwijnaarde, East Flanders Province, Belgium
When was argenx founded?
argenx's founding year is 2008
What is argenx's funding?
argenx's funding is -
What is argenx's current status?
argenx's current status is ipo
Top Argenx Employees
Head Of Commercial Analytics And Insights
lo_yingjui@yahoo.com
+4161-696-9511
Medical Research Liaison
lxyarbrough@yahoo.com
+1817-253-6381
Associate Director, Eu Medical Affairs Project Management
jennifer.gray@novartis.com
+4161-324-3846
Head, Global Patient Advocacy And Policy
kperez@halozyme.com
+1661-400-2411
Associate Director, Medical Affairs, Project Management
aprilshowerz23@yahoo.com
+1860-518-8355
Head Of Clinical And Pharmacovigilance Quality
mmcguire.qsp@gmail.com
+1931-647-2188
Director, Channel Operations
deborah.odonnell@alexion.com
+1203-271-8198
Vice President, Corporate Communications And Investor Relations
beth@sternir.com
+1212-362-1200